by Iga VonGeyso | Dec 18, 2023 | Article
The Inflation Reduction Act of 2022 triggered a flurry of Congressional bills to curb rising drug prices. The Congressional Budget Office (CBO) noted that the increased utilization of generics was not enough to offset the rising prices of brand drugs in recent years...
by Iga VonGeyso | Dec 18, 2023 | Article
Ozempic, Mounjaro, and Wegovy are some of the explosively popular GLP-1 drugs making headlines in 2023. GLP-1 stands for Glucagon-like Peptide-1, a hormone released during eating that prompts insulin production and increases feelings of satiety. GLP-1 Receptor...